Related Experiment Video

Updated: May 27, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Catheter ablation targeting complex fractionated atrial electrograms for the control of atrial fibrillation

Rajesh Kabra1, Jagmeet P Singh

  • 1Department of Medicine and Cardiac Electrophysiology, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA.

Current Opinion in Cardiology
|November 30, 2011
PubMed

Insights

Catheter ablation targeting complex fractionated atrial electrograms (CFAEs) improves outcomes for persistent atrial fibrillation but not paroxysmal atrial fibrillation. Further research is needed to standardize CFAE identification for better catheter ablation success.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Technology

Background:

  • Persistent atrial fibrillation (AF) has lower catheter ablation success rates than paroxysmal AF due to atrial remodeling.
  • Complex fractionated atrial electrograms (CFAEs) are targeted to eliminate AF substrates in persistent cases.
  • Understanding CFAE pathophysiology and significance is crucial for improving AF ablation outcomes.

Purpose of the Study:

  • To review the pathophysiology of atrial fibrillation (AF) and the role of targeting complex fractionated atrial electrograms (CFAEs) in catheter ablation.
  • To discuss recent studies on CFAE identification, distribution, and significance in AF.
  • To compare different ablation strategies targeting CFAEs with standard pulmonary vein isolation.

Main Methods:

  • Review of recent studies and meta-analyses on CFAE ablation in atrial fibrillation.
  • Comparison of CFAE-targeted ablation strategies versus pulmonary vein isolation.
  • Analysis of patient selection for CFAE ablation.

Main Results:

  • CFAE ablation, in addition to standard pulmonary vein isolation, enhances outcomes in persistent atrial fibrillation.
  • No significant benefit of CFAE ablation was observed in paroxysmal atrial fibrillation.
  • Recent meta-analyses aim to identify patient subgroups who benefit from CFAE ablation.

Conclusions:

  • CFAE ablation is beneficial for persistent atrial fibrillation but not for paroxysmal atrial fibrillation.
  • Standardization of CFAE definition and identification is necessary for improved catheter ablation success.
  • Further research is required to refine CFAE targeting for better long-term freedom from atrial fibrillation.
Abstract

More Related Videos

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...